Literature DB >> 22129964

Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients.

Marlieke Visser1, Mechteld A R Vermeulen, Milan C Richir, Tom Teerlink, Alexander P J Houdijk, Piet J Kostense, Willem Wisselink, Bas A J M de Mol, Paul A M van Leeuwen, Heleen M Oudemans-van Straaten.   

Abstract

In shock, organ perfusion is of vital importance because organ oxygenation is at risk. NO, the main endothelial-derived vasodilator, is crucial for organ perfusion and coronary patency. The availability of NO might depend on the balance between a substrate (arginine) and an inhibitor (asymmetric dimethylarginine; ADMA) of NO synthase. Therefore, we investigated the relationship of arginine, ADMA and their ratio with circulatory markers, disease severity, organ failure and mortality in shock patients. In forty-four patients with shock (cardiogenic n 17, septic n 27), we prospectively measured plasma arginine and ADMA at intensive care unit admission, Acute Physiology and Chronic Health Evaluation (APACHE) II-(predicted mortality) and Sequential Organ Failure Assessment (SOFA) score, and circulatory markers to investigate their relationship. Arginine concentration was decreased (34·6 (SD 17·9) μmol/l) while ADMA concentration was within the normal range (0·46 (SD 0·18) μmol/l), resulting in a decrease in the arginine:ADMA ratio. The ratio correlated with several circulatory markers (cardiac index, disseminated intravascular coagulation, bicarbonate, lactate and pH), APACHE II and SOFA score, creatine kinase and glucose. The arginine:ADMA ratio showed an association (OR 0·976, 95 % CI 0·963, 0·997, P = 0·025) and a diagnostic accuracy (area under the curve 0·721, 95 % CI 0·560, 0·882, P = 0·016) for hospital mortality, whereas the arginine or ADMA concentration alone or APACHE II-predicted mortality failed to do so. In conclusion, in shock patients, the imbalance of arginine and ADMA is related to circulatory failure, organ failure and disease severity, and predicts mortality. We propose a pathophysiological mechanism in shock: the imbalance of arginine and ADMA contributes to endothelial and cardiac dysfunction resulting in poor organ perfusion and organ failure, thereby increasing the risk of death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22129964     DOI: 10.1017/S0007114511004648

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  19 in total

1.  ADMA levels and arginine/ADMA ratios reflect severity of disease and extent of inflammation after subarachnoid hemorrhage.

Authors:  Cecilia Lindgren; Magnus Hultin; Lars-Owe D Koskinen; Peter Lindvall; Ljubisa Borota; Silvana Naredi
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

Review 2.  Chronic Critical Illness: Application of What We Know.

Authors:  Martin D Rosenthal; Amir Y Kamel; Cameron M Rosenthal; Scott Brakenridge; Chasen A Croft; Frederick A Moore
Journal:  Nutr Clin Pract       Date:  2018-01-11       Impact factor: 3.080

3.  Perspectives on the Immune System in Sepsis.

Authors:  Felician Stancioiu; Bogdan Ivanescu; Radu Dumitrescu
Journal:  Maedica (Bucur)       Date:  2022-06

4.  Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Alaadin Vögeli; Manuel Ottiger; Marc A Meier; Christian Steuer; Luca Bernasconi; Andreas Huber; Mirjam Christ-Crain; Christoph Henzen; Claus Hoess; Robert Thomann; Werner Zimmerli; Beat Mueller; Philipp Schuetz
Journal:  Lung       Date:  2017-08-29       Impact factor: 2.584

5.  Arginine appearance and nitric oxide synthesis in critically ill infants can be increased with a protein-energy-enriched enteral formula.

Authors:  Carlijn T I de Betue; Koen F M Joosten; Nicolaas E P Deutz; Anita C E Vreugdenhil; Dick A van Waardenburg
Journal:  Am J Clin Nutr       Date:  2013-08-14       Impact factor: 7.045

6.  The Arginine/ADMA Ratio Is Related to the Prevention of Atherosclerotic Plaques in Hypercholesterolemic Rabbits When Giving a Combined Therapy with Atorvastatine and Arginine.

Authors:  Saskia J H Brinkmann; Elisabeth A Wörner; Nikki Buijs; Milan Richir; Luc Cynober; Paul A M van Leeuwen; Rémy Couderc
Journal:  Int J Mol Sci       Date:  2015-05-29       Impact factor: 5.923

7.  Nutrition before and during Surgery and the Inflammatory Response of the Heart: A Randomized Controlled Trial.

Authors:  Marlieke Visser; Hans W M Niessen; Wouter E M Kok; Riccardo Cocchieri; Willem Wisselink; Paul A M van Leeuwen; Bas A J M de Mol
Journal:  J Nutr Metab       Date:  2015-07-29

Review 8.  Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model.

Authors:  Jiunn-Ming Sheen; Yu-Chieh Chen; You-Lin Tain; Li-Tung Huang
Journal:  Int J Mol Sci       Date:  2014-03-05       Impact factor: 5.923

9.  Determination of homoarginine, arginine, NMMA, ADMA, and SDMA in biological samples by HPLC-ESI-mass spectrometry.

Authors:  Luigi Servillo; Alfonso Giovane; Nunzia D'Onofrio; Rosario Casale; Domenico Cautela; Domenico Castaldo; Maria Luisa Balestrieri
Journal:  Int J Mol Sci       Date:  2013-10-09       Impact factor: 5.923

10.  Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management.

Authors:  Antoine Kossaify; Annie Garcia; Sami Succar; Antoine Ibrahim; Nicolas Moussallem; Mikhael Kossaify; Gilles Grollier
Journal:  Biomark Insights       Date:  2013-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.